Profile | GDS5420 / 239130_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 78.83 | 38 |
GSM1296119 | B_lesional_pre-dose | 83.79 | 37 |
GSM1296076 | C_lesional_pre-dose | 87.71 | 40 |
GSM1296092 | D_lesional_pre-dose | 82.1 | 41 |
GSM1296103 | E_lesional_pre-dose | 81.11 | 39 |
GSM1296078 | F_lesional_pre-dose | 99.15 | 43 |
GSM1296107 | G_lesional_pre-dose | 112.66 | 42 |
GSM1296109 | H_lesional_pre-dose | 110.24 | 41 |
GSM1296080 | I_lesional_pre-dose | 143.77 | 48 |
GSM1296090 | J_lesional_pre-dose | 130.65 | 47 |
GSM1296074 | K_lesional_pre-dose | 99.69 | 44 |
GSM1296111 | L_lesional_pre-dose | 96.42 | 39 |
GSM1296099 | M_lesional_pre-dose | 63.71 | 34 |
GSM1296086 | O_lesional_pre-dose | 112.76 | 45 |
GSM1296117 | P_lesional_pre-dose | 119.7 | 42 |
GSM1296113 | Q_lesional_pre-dose | 267.43 | 56 |
GSM1296096 | R_lesional_pre-dose | 58.32 | 34 |
GSM1296105 | S_lesional_pre-dose | 161.37 | 48 |
GSM1296098 | T_lesional_pre-dose | 144.12 | 47 |
GSM1296101 | U_lesional_pre-dose | 108.73 | 42 |
GSM1296121 | V_lesional_pre-dose | 63.9 | 33 |
GSM1296088 | W_lesional_pre-dose | 295.18 | 59 |
GSM1296082 | X_lesional_pre-dose | 124.19 | 46 |
GSM1296115 | Y_lesional_pre-dose | 96.34 | 39 |
GSM1296084 | Z_lesional_pre-dose | 160.2 | 49 |
GSM1296072 | B_lesional_day8 | 110.31 | 41 |
GSM1296069 | L_lesional_day8 | 145.57 | 45 |
GSM1296071 | P_lesional_day8 | 215.67 | 52 |
GSM1296070 | Y_lesional_day8 | 181.55 | 49 |
GSM1296073 | V_lesional_day8 | 81.68 | 37 |
GSM1296034 | A_lesional_day15 | 151.95 | 47 |
GSM1296041 | G_lesional_day15 | 89.29 | 38 |
GSM1296035 | R_lesional_day15 | 52.47 | 33 |
GSM1296038 | U_lesional_day15 | 87.96 | 40 |
GSM1296047 | B_lesional_day15 | 128.77 | 44 |
GSM1296039 | E_lesional_day15 | 63.59 | 35 |
GSM1296042 | H_lesional_day15 | 138.72 | 44 |
GSM1296043 | L_lesional_day15 | 149.18 | 45 |
GSM1296037 | M_lesional_day15 | 76.85 | 36 |
GSM1296046 | P_lesional_day15 | 109.78 | 40 |
GSM1296044 | Q_lesional_day15 | 317.3 | 59 |
GSM1296045 | Y_lesional_day15 | 195.54 | 50 |
GSM1296025 | C_lesional_day15 | 308.07 | 60 |
GSM1296033 | D_lesional_day15 | 171.59 | 50 |
GSM1296027 | I_lesional_day15 | 370.89 | 63 |
GSM1296032 | J_lesional_day15 | 317.35 | 60 |
GSM1296024 | K_lesional_day15 | 283.1 | 58 |
GSM1296031 | W_lesional_day15 | 324.9 | 60 |
GSM1296028 | X_lesional_day15 | 143.22 | 47 |
GSM1296029 | Z_lesional_day15 | 119.36 | 44 |
GSM1296026 | F_lesional_day15 | 166.98 | 50 |
GSM1296030 | O_lesional_day15 | 73.77 | 40 |
GSM1296040 | S_lesional_day15 | 131.73 | 45 |
GSM1296036 | T_lesional_day15 | 177.86 | 49 |
GSM1296048 | V_lesional_day15 | 76.15 | 36 |
GSM1296059 | A_lesional_day43 | 85.14 | 40 |
GSM1296066 | G_lesional_day43 | 136.11 | 44 |
GSM1296060 | R_lesional_day43 | 62.36 | 35 |
GSM1296063 | U_lesional_day43 | 98.96 | 41 |
GSM1296064 | E_lesional_day43 | 95.17 | 41 |
GSM1296067 | H_lesional_day43 | 176.71 | 48 |
GSM1296062 | M_lesional_day43 | 92.09 | 40 |
GSM1296068 | Q_lesional_day43 | 276.27 | 56 |
GSM1296050 | C_lesional_day43 | 177.6 | 51 |
GSM1296057 | D_lesional_day43 | 83.34 | 39 |
GSM1296052 | I_lesional_day43 | 431.77 | 66 |
GSM1296054 | J_lesional_day43 | 301.56 | 58 |
GSM1296049 | K_lesional_day43 | 182.17 | 51 |
GSM1296055 | W_lesional_day43 | 167.48 | 48 |
GSM1296053 | X_lesional_day43 | 323.23 | 60 |
GSM1296058 | Z_lesional_day43 | 61.44 | 35 |
GSM1296051 | F_lesional_day43 | 128.34 | 46 |
GSM1296056 | O_lesional_day43 | 47.89 | 32 |
GSM1296065 | S_lesional_day43 | 152.63 | 48 |
GSM1296061 | T_lesional_day43 | 135.18 | 46 |
GSM1296095 | A_non-lesional_pre-dose | 71.13 | 37 |
GSM1296120 | B_non-lesional_pre-dose | 77.65 | 35 |
GSM1296077 | C_non-lesional_pre-dose | 256.02 | 57 |
GSM1296093 | D_non-lesional_pre-dose | 279.29 | 57 |
GSM1296104 | E_non-lesional_pre-dose | 91.12 | 40 |
GSM1296079 | F_non-lesional_pre-dose | 208.85 | 54 |
GSM1296108 | G_non-lesional_pre-dose | 176.79 | 49 |
GSM1296110 | H_non-lesional_pre-dose | 272.65 | 56 |
GSM1296081 | I_non-lesional_pre-dose | 422.42 | 65 |
GSM1296091 | J_non-lesional_pre-dose | 206.98 | 54 |
GSM1296075 | K_non-lesional_pre-dose | 110.06 | 44 |
GSM1296112 | L_non-lesional_pre-dose | 250.6 | 54 |
GSM1296100 | M_non-lesional_pre-dose | 59 | 33 |
GSM1296087 | O_non-lesional_pre-dose | 321.32 | 61 |
GSM1296118 | P_non-lesional_pre-dose | 291.11 | 57 |
GSM1296114 | Q_non-lesional_pre-dose | 320.76 | 59 |
GSM1296097 | R_non-lesional_pre-dose | 119.59 | 44 |
GSM1296106 | S_non-lesional_pre-dose | 185.39 | 50 |
GSM1296102 | U_non-lesional_pre-dose | 165.25 | 48 |
GSM1296122 | V_non-lesional_pre-dose | 170.74 | 48 |
GSM1296089 | W_non-lesional_pre-dose | 265.5 | 56 |
GSM1296083 | X_non-lesional_pre-dose | 209.7 | 53 |
GSM1296116 | Y_non-lesional_pre-dose | 265.65 | 55 |
GSM1296085 | Z_non-lesional_pre-dose | 184.21 | 51 |